三星医疗：郭粟拟减持不超0.01%股份

Core Viewpoint - Samsung Medical (601567) announced that its director and board secretary, Ms. Guo Su, plans to reduce her holdings by a maximum of 150,000 shares, representing 0.01% of the company's total share capital, from October 24, 2025, to January 23, 2026 [1] Summary by Relevant Sections - Shareholding Details - Ms. Guo Su currently holds 600,000 shares, which is 0.04% of the company's total share capital, all obtained through equity incentives [1] - Impact on Company - The planned reduction will not have a significant impact on the company's governance structure or ongoing operations [1] - Reduction Method and Pricing - The share reduction will be executed through centralized bidding, with the selling price determined based on market conditions [1]